AngioDynamics financials
$15.60+0.39%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 May 31 | Q3 '26 Feb 28 | Q2 '26 Nov 30 | Q1 '26 Aug 31 | Q4 '25 May 31 | Q3 '25 Feb 28 | Q2 '25 Nov 30 | Q1 '25 Aug 31 | Q4 '24 May 31 | Q3 '24 Feb 29 | Q2 '24 Nov 30 | Q1 '24 Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $86.6M | $78.4M | $79.4M | $75.7M | $80.2M | $72.0M | $72.8M | $67.5M | $71.0M | $75.2M | $79.1M | $78.7M |
| Gross profit | $46.8M | $41.5M | $44.8M | $41.9M | $42.2M | $38.9M | $39.9M | $36.7M | $38.5M | $35.9M | $40.3M | $40.1M |
| Gross margin | 54.0% | 52.9% | 56.4% | 55.3% | 52.7% | 54.0% | 54.8% | 54.4% | 54.3% | 47.7% | 50.9% | 50.9% |
| Operating income | -$10.2M | -$13.0M | -$6.1M | -$10.7M | -$5.5M | -$10.0M | -$11.1M | -$13.1M | $40.0M | -$206.6M | -$13.1M | -$9.7M |
| Net income | -$11.4M | -$8.1M | -$6.3M | -$10.9M | -$6.0M | -$4.4M | -$10.7M | -$12.8M | -$13.4M | -$187.7M | -$29.0M | $45.9M |
| Net margin | −13.2% | −10.3% | −8.0% | −14.4% | −7.5% | −6.1% | −14.7% | −19.0% | −18.9% | −249.7% | −36.7% | 58.3% |
| Diluted EPS | $-0.27 | $-0.19 | $-0.15 | $-0.26 | $-0.15 | $-0.11 | $-0.26 | $-0.31 | $-0.33 | $-4.67 | $-0.72 | $1.15 |
| EBITDA | -$17.5M | -$838.0K | -$378.0K | -$4.6M | -$13.1M | -$369.0K | -$4.2M | -$6.3M | $40.0M | -$39.6M | -$26.0K | -$3.0M |
| Operating cash flow | $17.5M | -$3.1M | $4.7M | -$15.9M | $18.8M | -$13.2M | $2.5M | -$18.3M | $5.0M | -$12.4M | $5.2M | -$25.9M |
| Free cash flow | $15.4M | -$6.6M | $4.2M | -$16.6M | $15.7M | -$18.8M | $1.7M | -$19.3M | $4.4M | -$13.0M | $5.0M | -$27.5M |
| Diluted shares | 41.8M | 41.6M | 41.5M | 41.2M | 41.0M | 40.9M | 40.9M | 40.7M | 40.3M | 40.2M | 40.2M | 40.0M |
Balance sheet
| Period end | May 31 | Feb 28 | Nov 30 | Aug 31 | May 31 | Feb 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $53.9M | $37.8M | $41.6M | $38.8M | $55.9M | $44.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $267.2M | $260.7M | $269.7M | $265.6M | $280.1M | $285.4M |
| Total liabilities | $96.3M | $87.3M | $93.3M | $86.8M | $97.2M | $99.5M |
| Shareholders' equity | $170.8M | $173.4M | $176.3M | $178.9M | $183.0M | $185.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology